188 related articles for article (PubMed ID: 34877414)
1. Histone H3 lysine-trimethylation markers are decreased by recombinant methioninase and increased by methotrexate at concentrations which inhibit methionine-addicted osteosarcoma cell proliferation.
Aoki Y; Tome Y; Han Q; Yamamoto J; Hamada K; Masaki N; Bouvet M; Nishida K; Hoffman RM
Biochem Biophys Rep; 2021 Dec; 28():101177. PubMed ID: 34877414
[TBL] [Abstract][Full Text] [Related]
2. Extent and Instability of Trimethylation of Histone H3 Lysine Increases With Degree of Malignancy and Methionine Addiction.
Yamamoto J; Aoki Y; Inubushi S; Han Q; Hamada K; Tashiro Y; Miyake K; Matsuyama R; Bouvet M; Clarke SG; Endo I; Hoffman RM
Cancer Genomics Proteomics; 2022; 19(1):12-18. PubMed ID: 34949655
[TBL] [Abstract][Full Text] [Related]
3. Reversion of methionine addiction of osteosarcoma cells to methionine independence results in loss of malignancy, modulation of the epithelial-mesenchymal phenotype and alteration of histone-H3 lysine-methylation.
Aoki Y; Han Q; Tome Y; Yamamoto J; Kubota Y; Masaki N; Obara K; Hamada K; Wang JD; Inubushi S; Bouvet M; Clarke SG; Nishida K; Hoffman RM
Front Oncol; 2022; 12():1009548. PubMed ID: 36408173
[TBL] [Abstract][Full Text] [Related]
4. Histone methylation status of H3K4me3 and H3K9me3 under methionine restriction is unstable in methionine-addicted cancer cells, but stable in normal cells.
Yamamoto J; Han Q; Inubushi S; Sugisawa N; Hamada K; Nishino H; Miyake K; Kumamoto T; Matsuyama R; Bouvet M; Endo I; Hoffman RM
Biochem Biophys Res Commun; 2020 Dec; 533(4):1034-1038. PubMed ID: 33019978
[TBL] [Abstract][Full Text] [Related]
5. The Combination of Methioninase and Ethionine Exploits Methionine Addiction to Selectively Eradicate Osteosarcoma Cells and Not Normal Cells and Synergistically Down-regulates the Expression of
Aoki Y; Kubota Y; Han Q; Masaki N; Obara K; Bouvet M; Chawla SP; Tome Y; Nishida K; Hoffman RM
Cancer Genomics Proteomics; 2023 Dec; 20(6suppl):679-685. PubMed ID: 38035708
[TBL] [Abstract][Full Text] [Related]
6. Oral-recombinant Methioninase Converts an Osteosarcoma from Methotrexate-resistant to -sensitive in a Patient-derived Orthotopic-xenograft (PDOX) Mouse Model.
Aoki Y; Tome Y; Han Q; Yamamoto J; Hamada K; Masaki N; Kubota Y; Bouvet M; Nishida K; Hoffman RM
Anticancer Res; 2022 Feb; 42(2):731-737. PubMed ID: 35093871
[TBL] [Abstract][Full Text] [Related]
7. Deletion of
Aoki Y; Tome Y; Han Q; Yamamoto J; Hamada K; Masaki N; Kubota Y; Bouvet M; Nishida K; Hoffman RM
Cancer Genomics Proteomics; 2022; 19(3):299-304. PubMed ID: 35430564
[TBL] [Abstract][Full Text] [Related]
8. Linkage of methionine addiction, histone lysine hypermethylation, and malignancy.
Yamamoto J; Inubushi S; Han Q; Tashiro Y; Sugisawa N; Hamada K; Aoki Y; Miyake K; Matsuyama R; Bouvet M; Clarke SG; Endo I; Hoffman RM
iScience; 2022 Apr; 25(4):104162. PubMed ID: 35434545
[TBL] [Abstract][Full Text] [Related]
9. Oral-recombinant Methioninase Lowers the Effective Dose and Eliminates Toxicity of Cisplatinum for Primary Osteosarcoma of the Mammary Gland in a Patient-derived Orthotopic Xenograft Mouse Model.
Masaki N; Han Q; Wu NF; Samonte C; Wu J; Hozumi C; Obara K; Kubota Y; Aoki Y; Miyazaki J; Hoffman RM
In Vivo; 2022; 36(6):2598-2603. PubMed ID: 36309364
[TBL] [Abstract][Full Text] [Related]
10. Methylation Patterns of Lys9 and Lys27 on Histone H3 Correlate with Patient Outcome in Gastric Cancer.
Li Y; Guo D; Sun R; Chen P; Qian Q; Fan H
Dig Dis Sci; 2019 Feb; 64(2):439-446. PubMed ID: 30350241
[TBL] [Abstract][Full Text] [Related]
11. Oncogenes and Methionine Addiction of Cancer: Role of
Aoki Y; Han Q; Kubota Y; Masaki N; Obara K; Tome Y; Bouvet M; Nishida K; Hoffman RM
Cancer Genomics Proteomics; 2023; 20(2):165-170. PubMed ID: 36870694
[TBL] [Abstract][Full Text] [Related]
12. Synergy of Combining Methionine Restriction and Chemotherapy: The Disruptive Next Generation of Cancer Treatment.
Kubota Y; Han Q; Aoki Y; Masaki N; Obara K; Hamada K; Hozumi C; Wong ACW; Bouvet M; Tsunoda T; Hoffman RM
Cancer Diagn Progn; 2023; 3(3):272-281. PubMed ID: 37168964
[TBL] [Abstract][Full Text] [Related]
13. Effective Metabolic Targeting of Human Osteosarcoma Cells
Igarashi K; Kawaguchi K; Kiyuna T; Miyake K; Murakami T; Yamamoto N; Hayashi K; Kimura H; Miwa S; Tsuchiya H; Hoffman RM
Anticancer Res; 2017 Sep; 37(9):4807-4812. PubMed ID: 28870899
[TBL] [Abstract][Full Text] [Related]
14. Lowering and Stabilizing PSA Levels in Advanced-prostate Cancer Patients With Oral Methioninase.
Han Q; Hoffman RM
Anticancer Res; 2021 Apr; 41(4):1921-1926. PubMed ID: 33813397
[TBL] [Abstract][Full Text] [Related]
15. Targeting Methionine Addiction of Cancer Cells with Methioninase.
Pokrovsky VS; Qoura LA; Demidova EA; Han Q; Hoffman RM
Biochemistry (Mosc); 2023 Jul; 88(7):944-952. PubMed ID: 37751865
[TBL] [Abstract][Full Text] [Related]
16. Synergy of oral recombinant methioninase (rMETase) and 5-fluorouracil on poorly differentiated gastric cancer.
Miyake M; Miyake K; Han Q; Igarashi K; Kawaguchi K; Barangi M; Kiyuna T; Sugisawa N; Higuchi T; Oshiro H; Zhang Z; Razmjooei S; Bouvet M; Endo I; Hoffman RM
Biochem Biophys Res Commun; 2023 Feb; 643():48-54. PubMed ID: 36586158
[TBL] [Abstract][Full Text] [Related]
17. Selective Synergy of Rapamycin Combined With Methioninase on Cancer Cells Compared to Normal Cells.
Ardjmand D; Kubota Y; Sato M; Han Q; Mizuta K; Morinaga S; Hoffman RM
Anticancer Res; 2024 Mar; 44(3):929-933. PubMed ID: 38423628
[TBL] [Abstract][Full Text] [Related]
18. Oral dosing of Recombinant Methioninase Is Associated With a 70% Drop in PSA in a Patient With Bone-metastatic Prostate Cancer and 50% Reduction in Circulating Methionine in a High-stage Ovarian Cancer Patient.
Han Q; Tan Y; Hoffman RM
Anticancer Res; 2020 May; 40(5):2813-2819. PubMed ID: 32366428
[TBL] [Abstract][Full Text] [Related]
19. IOX-1 suppresses metastasis of osteosarcoma by upregulating histone H3 lysine trimethylation.
Chang SL; Lee CW; Yang CY; Lin ZC; Peng KT; Liu SC; Wang SW; Tsai HC; Fong YC; Lai CY; Huang YL; Tsai CH; Ko CY; Liu JF; Tang CH
Biochem Pharmacol; 2023 Apr; 210():115472. PubMed ID: 36863615
[TBL] [Abstract][Full Text] [Related]
20. Asymmetric and symmetric protein arginine methylation in methionine-addicted human cancer cells.
Holtz AG; Lowe TL; Aoki Y; Kubota Y; Hoffman RM; Clarke SG
PLoS One; 2023; 18(12):e0296291. PubMed ID: 38134182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]